Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II) - Trial NCT03878420
Access comprehensive clinical trial information for NCT03878420 through Pure Global AI's free database. This phase not specified trial is sponsored by LumiThera, Inc. and is currently Completed. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 44 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
LumiThera, Inc.
Timeline & Enrollment
N/A
Feb 14, 2019
Jan 22, 2021
Primary Outcome
Best Corrected Visual Acuity
Summary
This LIGHTSITE II study is a double-masked, sham-controlled, parallel design, prospective
 multi-site study for the use of PBM as a treatment for visual impairment in subjects with dry
 AMD.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03878420
Device Trial